Home

Turista Húzzák cement median overall survival for diffuse astrocytoma büfé Csipog Javítás

Extent of resection and molecular pathologic subtype are potent prognostic  factors of adult WHO grade II glioma | Scientific Reports
Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma | Scientific Reports

Predicting survival in anaplastic astrocytoma patients in a single-center  cohort of 108 patients | Radiation Oncology | Full Text
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text

Frontiers | Prognostic Factors Associated With Survival in Patients With Diffuse  Astrocytoma
Frontiers | Prognostic Factors Associated With Survival in Patients With Diffuse Astrocytoma

Biomedicines | Free Full-Text | The Current State of Adult Glial Tumor  Patients’ Care in Kazakhstan: Challenges in Diagnosis and Patterns in  Survival Outcomes
Biomedicines | Free Full-Text | The Current State of Adult Glial Tumor Patients’ Care in Kazakhstan: Challenges in Diagnosis and Patterns in Survival Outcomes

Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2  Mutations in Human Cancer: Prognostic Implications for Gliomas
Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas

Multidimensional scaling of diffuse gliomas: application to the 2016 World  Health Organization classification system with prognostically relevant  molecular subtype discovery | Acta Neuropathologica Communications | Full  Text
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery | Acta Neuropathologica Communications | Full Text

Astrocytoma Tumors – Symptoms, Diagnosis and Treatments
Astrocytoma Tumors – Symptoms, Diagnosis and Treatments

Risk factors for early progression of diffuse low-grade glioma in adults |  Chinese Neurosurgical Journal
Risk factors for early progression of diffuse low-grade glioma in adults | Chinese Neurosurgical Journal

Current therapeutic approaches to diffuse grade II and III gliomas -  Alberto Picca, Giulia Berzero, Marc Sanson, 2018
Current therapeutic approaches to diffuse grade II and III gliomas - Alberto Picca, Giulia Berzero, Marc Sanson, 2018

Overall survival of patients with diffuse astrocytomas. The presence of...  | Download Scientific Diagram
Overall survival of patients with diffuse astrocytomas. The presence of... | Download Scientific Diagram

A) Kaplan-Meier plots of 10-year survival by time period for patients... |  Download Scientific Diagram
A) Kaplan-Meier plots of 10-year survival by time period for patients... | Download Scientific Diagram

Glioma - Wikipedia
Glioma - Wikipedia

Spotlights on adult patients with pediatric-type diffuse gliomas in  accordance with the 2021 WHO classification of CNS tumors - Frontiers
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors - Frontiers

IDH1/2 mutation is a prognostic marker for survival and predicts response  to chemotherapy for grade II gliomas concomitantly treated with radiation  therapy
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy

A 25-year retrospective, single center analysis of 343 WHO grade II/III  glioma patients: implications for grading and temozolomide therapy |  Journal of Cancer Research and Clinical Oncology
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy | Journal of Cancer Research and Clinical Oncology

Kaplan-Meier overall survival of spinal cord astrocytoma by grade.... |  Download Scientific Diagram
Kaplan-Meier overall survival of spinal cord astrocytoma by grade.... | Download Scientific Diagram

Prognostic relevance of adding MRI data to WHO 2016 and cIMPACT‐NOW updates  for diffuse astrocytic tumors in adults. Working toward the extended use of  MRI data in integrated glioma diagnosis - Roux -
Prognostic relevance of adding MRI data to WHO 2016 and cIMPACT‐NOW updates for diffuse astrocytic tumors in adults. Working toward the extended use of MRI data in integrated glioma diagnosis - Roux -

Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified...  | Download Scientific Diagram
Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified... | Download Scientific Diagram

Astrocytoma progression scoring system based on the WHO 2016 criteria |  Scientific Reports
Astrocytoma progression scoring system based on the WHO 2016 criteria | Scientific Reports

Survival patterns of oligoastrocytoma patients: A surveillance,  epidemiology and end results (SEER) based analysis - ScienceDirect
Survival patterns of oligoastrocytoma patients: A surveillance, epidemiology and end results (SEER) based analysis - ScienceDirect

Predicting overall survival in diffuse glioma from the presurgical  connectome | Scientific Reports
Predicting overall survival in diffuse glioma from the presurgical connectome | Scientific Reports

Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified...  | Download Scientific Diagram
Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified... | Download Scientific Diagram

Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis |  Anticancer Research
Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis | Anticancer Research

Population-based study on incidence, survival rates, and genetic  alterations of low-grade diffuse astrocytomas and oligodendrogliomas |  SpringerLink
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas | SpringerLink

Kaplan–Meier survival curves for all lower-grade glioma and WHO 2016... |  Download Scientific Diagram
Kaplan–Meier survival curves for all lower-grade glioma and WHO 2016... | Download Scientific Diagram

Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution  Iran 2001-2010 - Iranian Journal of Neurosurgery
Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery